WASHINGTON — The federal government’s vaccine advisory panel is scheduled to review the hepatitis B vaccine this week. But experts on the shot — both in and outside of the government — told STAT they’ve been shut out of the process.
Makers of the vaccine, who hold safety data about the shot and house experts on its manufacturing and development, haven’t been consulted by government experts as they usually are, according to three people familiar with the matter who asked not to be identified because they were not authorized to speak publicly.
